Literature DB >> 29139625

Late graft failure after kidney transplantation as the consequence of late versus early events.

Robert S Gaston1, Ann Fieberg2, Lawrence Hunsicker3, Bertram L Kasiske4, Robert Leduc2, Fernando G Cosio5, Sita Gourishankar6, Joseph Grande5, Roslyn B Mannon1, David Rush7, J Michael Cecka8, John Connett2, Arthur J Matas2.   

Abstract

Beyond the first posttransplant year, 3% of kidney transplants fail annually. In a prospective, multicenter cohort study, we tested the relative impact of early versus late events on risk of long-term death-censored graft failure (DCGF). In grafts surviving at least 90 days, early events (acute rejection [AR] and delayed graft function [DGF] before day 90) were recorded; serum creatinine (Cr) at day 90 was defined as baseline. Thereafter, a 25% rise in serum Cr or new-onset proteinuria triggered graft biopsy (index biopsy, IBx), allowing comparison of risk of DCGF associated with early events (AR, DGF, baseline serum Cr >2.0 mg/dL) to that associated with later events (IBx). Among 3678 patients followed for 4.7 ± 1.9 years, 753 (20%) had IBx at a median of 15.3 months posttransplant. Early AR (HR = 1.77, P < .001) and elevated Cr at Day 90 (HR = 2.56, P < .0001) were associated with increased risk of DCGF; however, later-onset dysfunction requiring IBx had far greater impact (HR = 13.8, P < .0001). At 90 days, neither clinical characteristics nor early events distinguished those who subsequently did or did not undergo IBx or suffer DCGF. To improve long-term kidney allograft survival, management paradigms should promote prompt diagnosis and treatment of both early and later events.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  chronic allograft nephropathy; clinical research/practice; delayed graft function (DGF); kidney (allograft) function/dysfunction; kidney transplantation/nephrology; rejection: acute

Mesh:

Year:  2017        PMID: 29139625     DOI: 10.1111/ajt.14590

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  13 in total

1.  Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.

Authors:  William S Oetting; Baolin Wu; David P Schladt; Weihua Guan; Jessica van Setten; Brendan J Keating; David Iklé; Rory P Remmel; Casey R Dorr; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

2.  Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection.

Authors:  Weijia Zhang; Zhengzi Yi; Chengguo Wei; Karen L Keung; Zeguo Sun; Caixia Xi; Christopher Woytovich; Samira Farouk; Lorenzo Gallon; Madhav C Menon; Ciara Magee; Nader Najafian; Milagros D Samaniego; Arjang Djamali; Stephen I Alexander; Ivy A Rosales; Rex Neal Smith; Philip J O'Connell; Robert Colvin; Paolo Cravedi; Barbara Murphy
Journal:  JCI Insight       Date:  2019-06-06

3.  SARS-CoV-2 Vaccination in Kidney Transplant Recipients-Stratified Analysis of the Humoral Immune Response.

Authors:  Alexander Lammert; Peter Schnuelle; Holger F Rabenau; Sandra Ciesek; Bernhard K Krämer; Uwe Göttmann; Felix Drüschler; Christine Keller; Daniela Rose; Carsten Blume; Michael Thomas; Niko Kohmer; Anne Lammert
Journal:  Transplant Direct       Date:  2022-10-14

4.  Exploring the Complexity of Death-Censored Kidney Allograft Failure.

Authors:  Manuel Mayrdorfer; Lutz Liefeldt; Kaiyin Wu; Birgit Rudolph; Qiang Zhang; Frank Friedersdorff; Nils Lachmann; Danilo Schmidt; Bilgin Osmanodja; Marcel G Naik; Wiebke Duettmann; Fabian Halleck; Marina Merkel; Eva Schrezenmeier; Johannes Waiser; Michael Duerr; Klemens Budde
Journal:  J Am Soc Nephrol       Date:  2021-04-21       Impact factor: 14.978

5.  Correlation of Glomerular Size With Donor-Recipient Factors and With Response to Injury.

Authors:  Joseph P Grande; Erika S Helgeson; Arthur J Matas
Journal:  Transplantation       Date:  2021-11-01       Impact factor: 5.385

6.  Expanding the donor pool in kidney transplantation: Should organs with acute kidney injury be accepted?-A retrospective study.

Authors:  Katharina Schütte-Nütgen; Markus Finke; Sabrina Ehlert; Gerold Thölking; Hermann Pavenstädt; Barbara Suwelack; Daniel Palmes; Ralf Bahde; Raphael Koch; Stefan Reuter
Journal:  PLoS One       Date:  2019-03-13       Impact factor: 3.240

7.  Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.

Authors:  Qiang Fu; Minxue Liao; Cheng Feng; Jichao Tang; Rui Liao; Liang Wei; Hongji Yang; James F Markmann; Kai Chen; Shaoping Deng
Journal:  Aging (Albany NY)       Date:  2019-07-25       Impact factor: 5.682

8.  Risk Prediction for Delayed Allograft Function: Analysis of the Deterioration of Kidney Allograft Function (DeKAF) Study Data.

Authors:  Arthur J Matas; Erika Helgeson; Ann Fieberg; Robert Leduc; Robert S Gaston; Bertram L Kasiske; David Rush; Lawrence Hunsicker; Fernando Cosio; Joseph P Grande; J Michael Cecka; John Connett; Roslyn B Mannon
Journal:  Transplantation       Date:  2022-02-01       Impact factor: 5.385

9.  Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.

Authors:  Qian Niu; Aleixandra Mendoza Rojas; Marjolein Dieterich; Dave L Roelen; Marian C Clahsen-van Groningen; Lanlan Wang; Teun van Gelder; Dennis A Hesselink; Nicole M van Besouw; Carla C Baan
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

10.  Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis.

Authors:  Michael Eder; Christoph Schwarz; Michael Kammer; Niels Jacobsen; Masouridi Levrat Stavroula; Morton J Cowan; Tepsiri Chongkrairatanakul; Robert Gaston; Rommel Ravanan; Hideki Ishida; Anette Bachmann; Sergio Alvarez; Martina Koch; Cyril Garrouste; Ulrich A Duffner; Brett Cullis; Nicolaas Schaap; Michael Medinger; Søren Schwartz Sørensen; Eva-Maria Dauber; Georg Böhmig; Heinz Regele; Gabriela A Berlakovich; Thomas Wekerle; Rainer Oberbauer
Journal:  Am J Transplant       Date:  2018-07-13       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.